Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc operates in various business sectors.
Osmotica Pharmaceuticals plc (O1P) - Total Liabilities
Latest total liabilities as of June 2023: €69.08 Million EUR
Based on the latest financial reports, Osmotica Pharmaceuticals plc (O1P) has total liabilities worth €69.08 Million EUR as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Osmotica Pharmaceuticals plc - Total Liabilities Trend (2018–2022)
This chart illustrates how Osmotica Pharmaceuticals plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Osmotica Pharmaceuticals plc Competitors by Total Liabilities
The table below lists competitors of Osmotica Pharmaceuticals plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
United Rail Inc
PINK:URAL
|
USA | $1.63 Million |
|
Triad Pro Innovators Inc
PINK:TPII
|
USA | $1.26 Million |
|
Cann American Corp
PINK:CNNA
|
USA | $8.66 |
|
Gresham House Renewable Energy VCT 1 plc
LSE:GV1O
|
UK | GBX4.26 Million |
Liability Composition Analysis (2018–2022)
This chart breaks down Osmotica Pharmaceuticals plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Osmotica Pharmaceuticals plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Osmotica Pharmaceuticals plc (2018–2022)
The table below shows the annual total liabilities of Osmotica Pharmaceuticals plc from 2018 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | €77.42 Million | +13.95% |
| 2021-12-31 | €67.94 Million | -75.48% |
| 2020-12-31 | €277.09 Million | -20.50% |
| 2019-12-31 | €348.55 Million | -14.86% |
| 2018-12-31 | €409.38 Million | -- |